Retailers Push for Documented Dosage Consistency Standards
Pharmacy and specialty retailers replacing generic sugar-candy programs under mounting consumer verification pressure are increasingly specifying producers with documented dosage-consistency certification standing over legacy equivalents in shelf-placement decisions across most major functional-focused retail programs. Church & Dwight and Ferrara have both expanded certified formulation-testing capacity over the past two years to serve this growing consumer demand. At least a dozen major pharmacy chains have qualified new certified dosage-consistency partnerships since 2023, and producers report this shift is meaningfully expanding addressable functional demand across multiple product categories, with several additional retailers evaluating comparable programs soon internationally.
Market Impact: Sustains 4%+ income-linked growth yearly








